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Abstract One new cleistanthane-type diterpene named engleromycenolic acid A (1), one new rosane-type diterpene named
engleromycenolic acid B (2) and one new natural rosane-type diterpene, engleromycenol (3), along with three known rosane-
type diterpenes, rosololactone (4), rosenonolactone (5) and 7-deoxyrosenonolactone (6) were isolated from cultures of the
fungus Engleromyces goetzii, where it naturally grows on Alpine bamboo culms. The new compounds were elucidated based
on their spectroscopic data. In addition, compounds 1–6 were evaluated for their cholesterol ester transfer protein (CETP)
inhibition activity. This paper reports the isolation, structural elucidation, and CETP inhibition activity of these compounds.
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1 Introduction
The fungus Engleromyces goetzii is widely distributed in
Tibet, Sichuan and Yunnan province. It grows on Alpine
bamboo culms, and ripens during rainy season from July to
August. Local residents usually boil the fruiting bodies in
water to treat infection, inflammation and cancer [1–3].
Previous investigation on the fruiting bodies ofE. goetzii has
led to the isolation of neoengleromycin, cytochalasin D and
19,20-epoxycytochalasin D [4–6]. There are no reports about
the chemical constituents of the cultures of this fungus.
In order to search for more novel and potentially bioactive
secondary metabolites, the chemical constituents of E.
goetzii cultures were investigated by altering the culture
conditions of the fungus and enlarging the fermentation
scale. This investigation led to the isolation and identifica-
tion of one new cleistanthane-type diterpene named en-
gleromycenolic acid A (1), one new rosane-type diterpene
named engleromycenolic acid B (2) and one new natural
rosane-type diterpene named engleromycenol (3), along
with three known rosane-type diterpenes: rosololactone (4),
rosenonolactone (5) and 7-deoxyrosenonolactone (6) [7].
Their structures (Fig. 1) were elucidated based on the
spectroscopic data analyses. The cholesterol ester transfer
protein (CETP) inhibition activities of compounds 1–6 were
examined and engleromycenolic acid A (1) showed CETP
inhibition activity with IC50 value at 7.55 lM.
There are two kinds of lipoproteinsin plasma: one is
low-density lipoprotein (LDL) and another is high-density
lipoprotein (HDL) [8, 9]. They are in charge of carrying
cholesteryl esters in plasma. HDL is responsible for
transferring cholesteryl esters from periphery plasma to the
liver to metabolize, and LDL mediates the transport of
cholesteryl esters from the liver to periphery plasma [8, 10,
11]. CETP promotes the transfer of cholesteryl esters from
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HDL to LDL. Inhibiting the activity of CETP can promotes
the metabolism of cholesteryl esters in the liver and avoids
accumulation of cholesterol esters in plasma that may
cause atherosclerosis [9, 11–14].
2 Results and Discussion
Compound 1 was obtained as colorless oil, displayed an
[M?Na]? ion at m/z 341.2096 on the positive HRESIMS
analysis, corresponding to the molecular formula C20H30O3
with six degrees of unsaturation. The 1H NMR spectrum of
1 (Table 1) exhibited two methyls at dH 1.28 (3H, s) and
0.80 (3H, s), five olefinic protons at dH 5.69 (1H, ddd,
J = 17.1, 10.0, 10.0 Hz), 5.16 (1H, dd, J = 10.0, 2.2 Hz),
5.00 (1H, dd, J = 17.1, 2.2 Hz), 4.67 (1H, br.s) and 4.57
(1H, br.s). The 13C NMR spectrum showed 20 carbon
resonances, including one carboxyl, four sp2 olefinic car-
bons, one oxygen-bearing methine, two tertiary methyls,
six methylenes, four methines as well as two quaternary
carbons. These data suggested compound 1 might be a
tricyclic diterpene. The 1H and 13C NMR spectral data of 1
were similar to those of auricularic acid [15], which indi-
cated that 1 was a cleistanthane-type diterpene. However,
there are certain differences as follows: the resonance of
C-2 at dC 19.5 in auricularic acid is down shifted to dC 65.3
in 1, suggesting that the methylene at C-2 was replaced by
an oxygen-bearing methine. Furthermore, the HMBC cor-
relations from dH 2.41, 2.13, 1.00, 0.93 to carbon at dC
65.3, and the 1H–1H COSY correlations from dH 4.14 to dH
2.41, 2.13, 1.00 and 0.93 in 1, indicating that the oxygen-
bearing methane was placed at C-2. According to the
molecular formula, we can conclude the oxygen-bearing
methine at C-2 in 1 was substituted by a hydroxyl. In the
ROSEY spectrum, the observed cross peaks of CH3-20/H-
6b, H-2/CH3-20, CH3-20/H-8, H-8/H-15 and H-15/H-7b
suggested that H-2, H-8, H-15 H-7b, H-6b and CH3-20
were in the same side, whereas the cross peaks of H-6a/
CH3-19, H-9/H-14, H-7a/H-14 and H-7a/H-5 indicated that
H-6a, CH3-19, H-9, H-14, H-7a, H-14 and H-5 lied on the
opposite side (Fig. 2). Therefore, 1 was determined as
engleromycenolic acid A.
Compound 2 was isolated as white powder. The molecular
formula C20H30O3 was determined by the HRESIMS analysis
(m/z 341.2091 [M?Na]?), which indicated six degrees of
unsaturation. The 1H NMR spectrum (Table 2) of 2 exhibited
three olefinic protons at dH 5.87 (1H, dd, J = 17.5, 10.7 Hz),
4.97 (1H, dd, J = 17.5, 1.0 Hz) and 4.88 (1H, dd, J = 10.7,
1.0 Hz), one oxygen-bearing methine at dH 3.95 (1H, m) and
three methyls at dH 0.98 (3H, s), 1.08 (3H, s) and 1.31 (3H, s).
The 13C NMR spectrum showed 20 carbon resonances in-
cluding one carbonyl, four olefinic carbons, one oxygen-
bearing methine, three methyls, seven methylenes, one me-
thine and three quaternary carbons. Comparison of NMR data
of 2 with those of 7-deoxyrosenonolactone (6) [16], revealed
the presence of the characteristic signals of a rosane-type
diterpene. The resonances at dC 129.5 and 138.8 in the
13C
NMR spectrum of 2 suggested there was an additional double
bond in2. The HMBC correlations fromdH 2.42 and 1.86 todC
129.5,dH 1.31 todC 129.5;dH 2.22 and 1.97 todC 138.8 as well
as dH 0.98 to dC 138.8, indicated that the new double bond
located between C-5 and C-10. Based on the analysis, the
oxygen linkage between C-10 and C-18 in 6 was broken and
formed a carboxyl at C-18 in 2, which was confirmed by the
HMBC correlations from dH 2.21, 1.41 and 1.31 to dC 180.9.
In addition, the resonance of dC 21.7 (t) in 6 is down shifted to
dC 66.2 (d) in 2, indicated the methylene is oxidized by a
hydroxyl. The HMBC correlations from dH 2.42, 2.21, 1.86
and 1.41 to carbon at dC 66.2, as well as the
1H–1H COSY

























































Fig. 1 Structures of compounds 1–6
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suggesting the hydroxyl was attached to C-2. The ROSEY
spectrum showed cross peaks between CH3-20/H-2, H-1b/
CH3-20, H-1a/H-8, H-8/H-6a, CH3-19/H-6a and CH3-17/H-8
suggested CH3-20, H-2, H-1b in the same side, and H-1a, H-8,
H-6a, CH3-19 and CH3-17 in the opposite side (Fig. 3). The
detailed analysis of chemical shift and coupling constant led to
the determination that compound 2 was elucidated as en-
gleromycenolic acid B.
Compound 3 possessed a molecular formula C20H32O as
determined by the HRESIMS (m/z 311.2354, [M?Na]?),
which implied five degrees of unsaturation. The 1D NMR
spectroscopic data (Table 2) suggested that the backbone of 3
was the same as that of 2. Differences between them were
identified to be the loss of a carbonyl and an oxygen-bearing
methine, as well as the appearance of a hydroxymethyl and a
methylene. The HMBC correlations of dH 3.58 and 3.32 with
dC 23.6, 34.9 and 128.7 suggested the carbonyl at C-18 in 2 is
replaced by the hydroxymethyl (dC 69.9, dH 3.58 and 3.32) in
3. In addition, the HMBC correlation from dH 1.68 and 1.58 to
dC 142.5 and 39.3, and the
1H–1H COSY correlation from dH
1.98 to dH 1.68 and 1.58, dH 1.68 and 1.58 to dH 1.78 and 1.27,
indicated that the oxygen-bearing methine at C-2 in 2 was
replaced by a methylene in 3. The configuration of C-8, C-9
and C-13 were established by comparing the NMR data of 3
with 2. The H-3 signal at dH 1.78 (1H, ddd, J = 13.5, 5.0,
3.5 Hz) suggested it to be equatorial b-oriented. In the
ROSEY spectrum, the observed cross peak ofdH 1.78 and 3.32
indicated the hydroxymethyl group in C-4 was located in axial
b-oriented. In addition, there are no cross peak between H-18
(3.58, 3.32) and H-3a (1.27) in ROSEY spectrum, which
further approved the conclusion above (Fig. 4). According to
this analysis, compound 3 was confirmed as engleromycenol.
Based on the spectroscopic analyses and the comparison
with the literature, the known compounds were identified as
rosololactone (4) [17, 18], rosenonolactone (5) [18] and
7-deoxyrosenonolactone (6) [16]. Compound 3 has been re-
ported in the conversion of 7-deoxyrosenonolactone to 3 by
Connolly [19]. However, there are no reports about the NMR
data of 3.
All the isolates were assayed for their CETP inhibition
activity with the CETP Inhibitor Drug Screening Kit. The
result showed that compounds 2–6 exhibited weak
Table 1 1H and 13C NMR spectroscopic data for compound 1
Pos. dC Type dH (J in Hz)
1 49.3, t 2.13 (ddd 12.3, 4.3, 1.9, H-b)
0.93, overlapped
2 65.3, d 4.14 (tt, 11.5,4.3, H-b)
3 47.7, t 2.41 (ddd 12.3, 4.3, 1.9, H-b)
1.00, overlapped
4 46.0, s
5 56.6, d 1.15, overlapped
6 24.3, t 1.92, overlapped
1.74 (dddd 13.5, 13.5, 13.5, 3.5, H-b)
7 35.3, t 2.02 (dq-like, 13.3, 3.6, H-b)
0.89 (qd-like, 13.3, 3.6, H-a)
8 42.8, d 1.17, overlapped
9 55.8, d 1.03, overlapped
10 40.0, s
11 28.1, t 1.93, overlapped, H-a
1.12, overlapped, H-b
12 37.0, t 2.45 (ddd, 13.1, 3.2, 3.2, H-b)
2.06, overlapped
13 152.4, s
14 56.0, d 2.28 (dd, 10.0, 10.0)
15 141.2, d 5.69 (ddd, 17.1, 10.0, 10.0)
16 116.9, t 5.16 (dd,10.0, 2.2)
5.00 (dd, 17.1, 2.2)
17 106.8, t 4.67 br.s
4.57 br.s
18 181.2, s
19 29.5, q 1.28, s
20 14.4, q 0.80, s






H C HMBC COSY H H ROSEY
Fig. 2 Selected 2D NMR correlations of 1
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inhibition activity of CETP, however, engleromycenolic
acid A (1) significantly inhibited the activity of CETP with
the IC50 value at 7.55 lM. Results of the study suggested
that engleromycenolic acid A (1) might be a good candi-
date to develop effective therapeutic agent for the treat-
ment of atherosclerotic cardiovascular diseases.
3 Experimental Section
3.1 General Experimental Procedures
The optical rotations were measured on a JASCO model 1020
polarimeter (JASCO International Co., Ltd., Tokyo, Japan).
The IR spectra were obtained on a Bruker TENSOR 27FT-IR
spectrometer (Bruker, Ettlingen, Germany) using KBr pellets.
The 1D and 2D NMR data were performed on Bruker Avance
III 600 and AM-400 instruments (Bruker, Rheinstetten, Ger-
many) at room temperature. The chemical shifts (d) were
expressed in ppm with reference to the solvent signals. The
mass spectra (MS) were acquired on an API QSTAR time-of-
flight mass spectrometer (MDS Sciex, Ontario, Canada) or a
VG Autospec-3000 spectrometer (VG, Manchester, Eng-
land). Silica gel (200–300 mesh, Qingdao Marine Chemical
Inc., Qingdao, China), Sephadex LH-20 (Amersham Bio-
sciences, Sweden), and RP-18 gel (40–75 lm, Fuji Silysia
Chemical Ltd., Japan) were used for column chromatography.
Preparative HPLC (Prep-HPLC) was performed on an Agilent
1100 liquid chromatography system equipped with a ZOR-
BAX SB-C18 column (9.4 mm 9 150 mm). Precoated silica
Table 2 1H and 13C NMR spectroscopic data for compounds 2 and 3
Pos. 2a 3b
dC Type dH (J in Hz) dC Type dH (J in Hz)
1 35.4, t 2.42 (dd, 15.9, 3.8, H-b)
1.86, m, H-a
25.0, t 1.98, overlapped
2 66.2, d 3.95, m 19.7, t 1.68, overlapped
1.58, overlapped
3 45.8, t 2.21, overlapped
1.41, overlapped
34.9, t 1.78 (ddd, 13.5, 5.0, 3.5, H-b)
1.27, overlapped
4 49.8, s 39.3, s
5 129.5, s 128.7, s
6 28.1, t 2.22, overlapped, H-a
1.97 (dd,16.9, 5.4, H-b)
25.2, t 2.10, overlapped
1.96, overlapped
7 26.5, t 1.51, overlapped
1.34, overlapped
25.8, t 1.39, overlapped
1.32, overlapped
8 38.9, d 1.65, overlapped 37.5, d 1.59, overlapped
9 38.6, s 37.8, s
10 138.8, s 142.5, s
11 32.6, t 1.68, overlapped
1.39, overlapped
31.7, t 1.61, overlapped
1.33, overlapped
12 33.5, t 1.64, overlapped
1.33, overlapped
32.7, t 1.54, overlapped
1.27, overlapped
13 37.3, s 36.4, s
14 40.6, t 1.48, overlapped, H-b
1.13 (br.d, 13.1, H-a)
39.8, t 1.38, overlapped
1.07, overlapped
15 152.2, d 5.87 (dd,17.5, 10.7) 151.4, d 5.82 (dd, 17.4, 10.7)
16 109.2, t 4.97 (dd, 17.5, 1.0)
4.88 (dd, 10.7, 1.0)
108.8, t 4.92 (dd, 17.4, 1.2)
4.85 (dd, 10.7, 1.2)
17 23.5, q 1.08, s 23.1, q 1.03, s
18 180.9, s 69.9, t 3.58(d, 10.8)
3.32(d, 10.8)
19 25.3, q 1.31, s 23.6, q 0.95, s
20 16.7, q 0.98, s 17.9, q 0.88, s
a Spectra were measured in CD3OD at 600 MHz
b Spectra were measured in CDCl3 at 400 MHz
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gel GF254 plates (Qingdao Marine Chemical Inc., Qingdao,
China) were used for TLC analysis. The fractions were
monitored by TLC analysis, and spots were visualized under
UV light (254 or 365 nm) or by heating silica gel plates
sprayed with 10 % H2SO4 in ethanol.
3.2 Fungal Material and Cultivation Conditions
Fruiting bodies of E. goetzii were collected from Shangri-La
county in Yunnan Province, China. A voucher specimen has
been deposited in the Herbarium of the Kunming Institute of
Botany of the Chinese Academy of Sciences. The mycelia
cultures were derived from the tissue plugs. The culture PDA
medium consisted of glucose (5 %), peptone from porcine
meat (0.15 %), yeast powder (0.5 %), KH2PO4 (0.05 %) and
MgSO4 (0.05 %). The inoculums ofE. goetziiwere prepared
in a 15 L-fermentation tank for 6 days under the following
conditions: culture temperature, 24 C; initial pH, 6.0;
agitation speed, 250 r/min; inoculation volume, 10 % (by
volume); and aeration rate, 1.0 volume/culture volume/min.
Subsequently, the liquid seed was transferred into a 100
L-fermentation tank for cultivation under the same condi-
tions for 20 days to afford an 80 L culture broth.
3.3 Extraction and Isolation
The fermentation broth (80 L) was filtered, and the filtrate was
concentrated to 10 L under reduced pressure and then extracted
with ethyl acetate (3 9 10 L). The organic layer was
evaporated to give a crude extract (350 g). Subsequently, the
extract was subjected to silica gel column chromatography,
using a petroleum ether/acetone gradient (100:0 ? 0:100 V/V)
to afford fractions F1–F7 based on TLC analysis. F3 was
purified using Sephadex LH-20 column chromatography
(chloroform/methanol = 1:1 V/V) and then subjected to
silica gel column chromatography (petroleum ether/ace-
tone = 100:1 V/V) to afford compound 6 (50.0 mg). F4 was
fractioned by Sephadex LH-20 (chloroform/metha-
nol = 1:1 V/V) and then subjected to silica gel with a pet-
roleum ether/acetone system (150:1 V/V) to give compound
5 (15.1 mg). F5 was separated by silica gel column chro-
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F5-1 and F5-2. F5-1 was further purified by Sephadex LH-20
column chromatography (chloroform/methanol = 1:1 V/V)
to afford compound 4 (13.3 mg). F5-2 was separated with
silica gel column chromatography (chloroform/metha-
nol = 150:1 V/V) and Sephadex LH-20 column chro-
matography (chloroform/methanol = 1:1 V/V) to give F5-2-1
and F5-2-2. F5-2-1 was separated by preparative HPLC (ace-
tonitrile/water = 3:7 ? 6:4 V/V) to provide compound 1
(18.0 mg) and 2 (10.6 mg). F7 was purified by Sephadex LH-
20 column chromatography (chloroform/methanol = 1:1
V/V) and RP-18 gel (methanol/water = 1:1 V/V) to give
compound 3 (30.8 mg).
3.4 Engleromycenolic Acid A (1)
Colorless oil; ½a21:2D ?30.5 (c 0.23, MeOH); IR (KBr) vmax
3446, 3080, 2943, 2863, 1693, 1642, 1467, 1447,
1200 cm-1; 1H and 13C NMR data see Table 1; ESIMS
(negative)m/z 317 (100) [M-H]-; HRESIMS (positive)m/z
341.2096 [M?Na]? (calcd for C20H30O3Na, 341.2093).
3.5 Engleromycenolic Acid B (2)
White powder; ½a24:6D –166.3 (c 0.32, MeOH); IR (KBr) vmax
3440, 3082, 2928, 2871, 1700, 1635, 1465, 1233 cm-1; 1H
and 13C NMR data see Table 2; ESIMS (negative) m/z 317
(100) [M-H]-; HRESIMS (positive) m/z 341.2091
[M?Na]? (calcd for C20H30O3Na, 341.2093).
3.6 Engleromycenol (3)
White powder; ½a24:5D -139.1 (c 0.13, MeOH); IR (KBr)
vmax 3440, 3082, 2927, 2876, 1637, 1462, 1434, 1376,
1199 cm-1; 1H and 13C NMR data see Table 2; ESIMS
(positive) m/z 311 (40) [M?Na]?; HRESIMS (positive)
m/z 311.2354 [M?Na]? (calcd for C20H32ONa, 311.2351).
3.7 CETP Inhibition Activity Assay
Cholesterol ester transfer protein inhibition activity assay
were carried out using a CETP Inhibitor Screening Kit
(BioVision Incorporated., Milpitas, USA). CETP is a
member of the lipid transfer/lipopolysaccharide binding
protein gene family. CETP transfers neutral lipids from
HDL to LDL and is present in normal human plasma
and serum. The CETP Drug Screening Kit uses a donor
molecule containing a fluorescent self-quenched neutral
lipid that is transferred to an acceptor molecule in the
presence of CETP (rabbit serum). CETP-mediated
transfer of the fluorescent neutral lipid to the acceptor
molecule results in an increase in fluorescence
(ExEm = 465/535 nm). Inhibitor of CETP will inhibit
the lipid transfer and subsequently decrease fluorescence
intensity. The assay was carried out in a microtiter plate.
Reagents were kept on ice prior to setting up the assay.
The reaction mixture, containing test sample in 160 lL
dH2O or control vehicle (160 lL dH2O); 20 lL CETP
assay buffer; 10 lL of donor molecule and 10 lL of
acceptor molecule was mixed well. The reaction was
initiated by the addition of 3 lL of rabbit serum. After
60 min of incubation at 37 C, transfer was measured by
the fluorescence intensity with BioTek Instrument (Gene
Company Limited., USA). Background values were ob-
tained from a blank with 160 lL dH2O. Percent inhibi-
tion of CETP activity was calculated by subtracting the
background values from both control and test sample
values. The IC50 value was calculated by Reed and
Muench’s method.
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